Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report

J Clin Psychiatry. 2006 Aug;67(8):1307. doi: 10.4088/jcp.v67n0821a.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / pharmacology
  • Antipsychotic Agents / therapeutic use*
  • Aripiprazole
  • Dyslipidemias / chemically induced*
  • Dyslipidemias / drug therapy*
  • Female
  • Humans
  • Hyperprolactinemia / chemically induced*
  • Hyperprolactinemia / drug therapy*
  • Obesity / chemically induced*
  • Obesity / drug therapy*
  • Piperazines / pharmacology
  • Piperazines / therapeutic use*
  • Quinolones / pharmacology
  • Quinolones / therapeutic use*
  • Risperidone / adverse effects*
  • Risperidone / therapeutic use
  • Schizophrenia, Paranoid / drug therapy*
  • Treatment Outcome
  • Weight Gain / drug effects

Substances

  • Antipsychotic Agents
  • Piperazines
  • Quinolones
  • Aripiprazole
  • Risperidone